A New and Immersive Medical Device for Cognitive Assessment Testing

Altoida’s medical device for cognitive assessment measures brain health in 10 minutes with a battery of immersive augmented reality (AR) activities.

Cognitive Assessment Device Features

By engaging in a set of activities that feel like games but simulate complex tasks of daily living, Altoida’s medical device for cognitive assessment turns any smartphone or tablet into the world’s most powerful brain monitor. Users and their providers gain access to personalized and actionable brain health measurements.

Immersive AR

Altoida’s game-like AR and digital motor activities simulate complex activities of daily living.

10 Minutes

Altoida’s activity battery is designed to be completed in only 10 minutes.

Any Location

Altoida’s cognitive assessment activities can be completed from the comfort of your own home.

Benefits of Early and Continuous Brain Monitoring

When given access to better tools to regularly monitor brain health and diagnose neurological diseases in their beginning stages, individuals can benefit from an earlier understanding and more management options. Early diagnosis can enable early intervention.

explore our technology

Testimonials

The Altoida technology will be applicable in the direct care of patients and for research to help provide the next generation of therapeutic products. A test that will be easy to obtain, simple to perform, readily available, affordable, instantly diagnostic, reliable, and can establish efficaciousness is a remarkable breakthrough in medicine.

Charles Neblett, M.D., Neurosurgeon, Baylor College of Medicine and Consultant/Medical Director at McNair Medical Institute, Houston TX

The Altoida technology offers an ingenious way in which to detect early disease and track progression without prolonged cognitive testing, tissue sampling, or radiologic intervention. The Altoida technology is a welcomed advancement to the field of cognitive health.

Jonathan L. Liss, M.D., Director at Columbus Memory Center and Founder of Columbus Memory Project

Diagnosis of an individual at risk for Alzheimer’s disease has been the biggest challenge in the field of Alzheimer’s disease and the Altoida digital biomarker technology will provide us with an innovative tool to detect the onset of Alzheimer’s disease in a reliable and gamified fashion.

Dr. Namrata Das M.D., MPH, Center for BrainHealth, The University of Texas at Dallas

our partners

Revolutionizing brain heath takes an army — we are proud to have partnered with

Published Research

Altoida's Methodology Supported By Research

Altoida's recent publication in Nature Digital Medicine, well summarized in this Nature community blog post, showed Altoida's device (referred to by the updated name Digital neuro-signature, or DNS):

More efficient than traditional methods: "...by comparison to conventional neuropsychological assessments, [DNS] results in faster evaluations (10 min vs 45–120 min)."

More accurate than traditional methods: "...higher accuracy at detecting abnormal cognition [compared to traditional neuropsychological assessments like MMSE and MoCA].”

More sensitive to change over time than traditional methods: “...consistently more sensitive than traditional neuropsychological assessments at capturing longitudinal individual-level change.”

Together We Can Revolutionize Brain Health

To learn more about how Altoida is building the precision neurology platform to power early Alzheimer’s disease diagnosis and personalized brain analysis, contact us.

CONNECT WITH US